Description
The storyline:
Fresenius SE & Co. KGaA is a global health care group headquartered in Bad Homburg, Germany. Fresenius currently has four subsidiaries: Fresenius Kabi, Fresenius Medical Care, Fresenius Vamed and Fresenius Helios. Fresenius Medical Care, headquartered in Massachusetts, USA, is the world’s leading provider of dialysis treatments and products for kidney patients.
This subsidiary also provides medical care coordination services. Fresenius Kabi, for its part, specialises in products and services for the care of chronically and critically ill patients. Its products include technologies and drugs for infusions, clinical nutrition and transfusions. Fresenius Helios is the leading private hospital operator in Europe. The holding company owns and operates the Quirónsalud hospitals in Spain and the Helios clinics in Germany. Fresenius Vamed, based in Vienna, Austria, provides post-acute services and manages projects worldwide.
To enhance shareholder value and increase profits, Fresenius Helios plans to enter the UK and US healthcare markets through the acquisition of HCA Healthcare, Inc. HCA Healthcare is a publicly-traded company listed on the New York Stock Exchange and the London Stock Exchange. Therefore, a valuation needs to be undertaken for HCA Healthcare.
This order – Please cover the following topics:
– The most common valuation methods – with a short explanation. Pro and cons.
-Recommend the method Discounted Cash Flow Valuation for Fresenius Helios to evaluate HCA Healthcare (the storyline mentioned above). Explain why and elaborate on this method linking to the case.
